In Vitro Inhibition of Multiple Cytochrome P450 Isoforms by Xanthone Derivatives from Mangosteen Extract

被引:32
作者
Foti, Robert S. [1 ]
Pearson, Josh T. [1 ]
Rock, Dan A. [1 ]
Wahlstrom, Jan L. [1 ]
Wienkers, Larry C. [1 ]
机构
[1] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
关键词
GARCINIA-MANGOSTANA; DRUG-INTERACTIONS; GAMMA-MANGOSTIN; SERENOA-REPENS; 3A4; 2D6; CONSTITUENTS; GINSENOSIDES; ANTIOXIDANT; SUPPLEMENTS;
D O I
10.1124/dmd.109.028043
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Mangosteen is a xanthone-containing fruit found in Southeast Asia for which health claims include maintaining healthy immune and gastrointestinal systems to slowing the progression of tumor growth and neurodegenerative diseases. Previous studies have identified multiple xanthones in the pericarp of the mangosteen fruit. The aim of the current study was to assess the drug inhibition potential of mangosteen in vitro as well as the cytochrome P450 (P450) enzymes responsible for the metabolism of its individual components. The various xanthone derivatives were found to be both substrates and inhibitors for multiple P450 isoforms. Aqueous extracts of the mangosteen pericarp were analyzed for xanthone content as well as inhibition potency. Finally, in vivo plasma concentrations of alpha-mangostin, the most abundant xanthone derivative found in mangosteen, were predicted using Simcyp and found to be well above their respective in vitro K-i values for CYP2C8 and CYP2C9.
引用
收藏
页码:1848 / 1855
页数:8
相关论文
共 37 条
[1]
Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity [J].
Balunas, Marcy J. ;
Su, Bin ;
Brueggemeier, Robert W. ;
Kinghorn, A. Douglas .
JOURNAL OF NATURAL PRODUCTS, 2008, 71 (07) :1161-1166
[2]
The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective [J].
Bjornsson, TD ;
Callaghan, JT ;
Einolf, HJ ;
Fischer, V ;
Gan, L ;
Grimm, S ;
Kao, J ;
King, SP ;
Miwa, G ;
Ni, L ;
Kumar, G ;
McLeod, J ;
Obach, RS ;
Roberts, S ;
Roe, A ;
Shah, A ;
Snikeris, F ;
Sullivan, JT ;
Tweedie, D ;
Vega, JM ;
Walsh, J ;
Wrighton, SA .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (07) :815-832
[3]
Blumenthal T.C., 2006, HERB GRAM, P64
[4]
BOLLAG DM, 1995, CANCER RES, V55, P2325
[5]
Management of narrow therapeutic index drugs [J].
Burns, M .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 1999, 7 (02) :137-143
[6]
In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1 [J].
Chang, TKH ;
Chen, J ;
Benetton, SA .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (04) :378-384
[7]
Active constituents against HIV-1 protease from Garcinia mangostana [J].
Chen, SX ;
Wan, M ;
Loh, BN .
PLANTA MEDICA, 1996, 62 (04) :381-382
[8]
Craig WJ, 1999, AM J CLIN NUTR, V70, p491S, DOI 10.1093/ajcn/70.3.491s
[9]
Biochemical and Therapeutic Effects of Antioxidants in the Treatment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis [J].
Di Matteo, Vincenzo ;
Esposito, Ennio .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2003, 2 (02) :95-107
[10]
Foster BC, 2001, J PHARM PHARM SCI, V4, P176